<DOC>
	<DOCNO>NCT00282932</DOCNO>
	<brief_summary>An interventional active/placebo double blind parallel randomize control study 12 week treatment , primary endpoint patient perception bladder condition measure along associate safety secondary endpoint like bladder diary endpoint , quality life patient treatment satisfaction . Patients include study must symptoms OAB ( frequency least 8 per day Urgency least 1 episode per day confirm bladder diary ) . Patients eligible enroll study have/had significant hepatic renal disease , history radiation treatment .</brief_summary>
	<brief_title>Detrol LA In Men With Overactive Bladder .</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Symptoms OAB ( frequency 8 per day Urgency 1 episode per day confirm bladder diary ) Significant hepatic renal disease , history radiation treatment</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>